Last updated: March 2, 2024
Sponsor: Zeng Changhao
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heartburn
Nasopharyngeal Cancer
Treatment
Nasogastric Tube Feeding
Intermittent Oral-esophageal Tube Feeding
comprehensive rehabilitation therapy
Clinical Study ID
NCT06265844
IOE-Biyanai
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age between 18 and 65 years.
- With the history of NPC and radiation therapy.
- With dysphagia occurred at least three years after radiotherapy (confirmed byvideofluoroscopic swallowing study), in need of and feasible for enteral nutritionsupport.
- Conscious and with stable vital signs;
- Willing to participate and sign the written informed consent form either personally orby a family member.
Exclusion
Exclusion Criteria:
- Presence of other diseases that might cause dysphagia.
- With distant metastasis of tumors, or complicated with severe systemic disorders ormalignancies.
- Concurrent participation in other treatments that could interfere with the trial.
- Inability to cooperate with treatment due to aphasia, mental health issues, etc.
- Received tube feeding for enteral nutrition support within the past three years.
Study Design
Total Participants: 80
Treatment Group(s): 3
Primary Treatment: Nasogastric Tube Feeding
Phase:
Study Start date:
March 01, 2024
Estimated Completion Date:
September 30, 2024
Study Description
Connect with a study center
Peking University Sixth Hospital
Beijing, Beijing 101499
ChinaSite Not Available
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong 510000
ChinaSite Not Available
Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan 450000
ChinaSite Not Available
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan 450000
ChinaSite Not Available
Saint Martin Hospital
Hong Kong,
Hong KongActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.